Skip to main content

Human Macrophages May Normally be “Primed” for a Strong Oxygen Radical Response

  • Chapter
Biological Response Modifiers in Human Oncology and Immunology

Abstract

In previous work we showed that macrophages must produce oxygen radicals in order to kill pathogenic organisms (1). Oxygen radical production by mouse peritoneal macrophages could be enhanced at least ten-fold if the macrophages were previously “activated”. (Throughout this paper we use the term “activated” to mean “primed to release optimal amounts of O 2 when stimulated”). Macrophages were activated either by infecting the animals with Mycobacterium bovis, strain BCG, or by injecting them with bacterial lipopolysaccharide (LPS) or muramyl dipeptide (MDP) (2, 3). Cultured macrophages could also be activated in vitro by addition of LPS or MDP to the cultures (4). Treatment with LPS or MDP enhanced the ability of cultured macrophages to kill bacteria and fungi in vitro (1, 3). Treatment of mice with MDP in vivo enabled them to resist an otherwise lethal challenge infection with Klebsiella pneumoniae or Candida albicans (3, 5).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sasada, M., and R. B. Johnston, Jr. 1980. Macrophage microbicidal activity. Correlation between phagocytosis-associated oxidative metabolism and the killing of Candida by macrophages. J. Exp. Med. 152: 85.

    Article  PubMed  CAS  Google Scholar 

  2. Johnston, R. B., Jr., C. A. Godzik and Z. A. Cohn. 1978. Increased superoxide anion production by immunologically activated and chemically elicited macrophages. J. Exp. Med. 148: 115.

    Article  PubMed  CAS  Google Scholar 

  3. Cummings, N. P., M. J. Pabst and R. B. Johnston, Jr. 1980. Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide. J. Exp. Med. 152: 1659.

    Article  PubMed  CAS  Google Scholar 

  4. Pabst, M. J. and R. B. Johnston, Jr. 1980. Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide. J. Exp. Med. 151: 101.

    Article  PubMed  CAS  Google Scholar 

  5. Chedid, L., M. Parant, F. Parant, F. Audibert, F. LeFrancier, J. Choay, and M. Sela. 1979. Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly (DL-alanine)-poly(L-lysine) carrier. Proc. Natl. Acad. Sci. 76: 6557.

    Article  PubMed  CAS  Google Scholar 

  6. Pabst, M. J., H. B. Hedesgaard, and R. B. Johnston, Jr. 1982. Cultured human monocytes require exposure to bacterial products to maintain an optimal oxygen radical response. J. Immunol. 128: 123.

    PubMed  CAS  Google Scholar 

  7. Hedegaard, H. B., and M. J. Pabst. 1982. Preservation of superoxide anion-generating capacity in cultured human monocytes by treatment with muramyl dipeptide or lipopolysaccharide, p. 205 208. Y. Yamamura et al (eds.), In Immunomodulation by Microbial Products and Related Synthetic Compounds. Excerpta Medica, Amsterdam.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer Science+Business Media New York

About this chapter

Cite this chapter

Pabst, M.J., Cummings, N.P., Hedegaard, H.B., Johnston, R.B. (1983). Human Macrophages May Normally be “Primed” for a Strong Oxygen Radical Response. In: Klein, T., Specter, S., Friedman, H., Szentivanyi, A. (eds) Biological Response Modifiers in Human Oncology and Immunology. Advances in Experimental Medicine and Biology, vol 166. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1410-4_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-1410-4_18

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-1412-8

  • Online ISBN: 978-1-4757-1410-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics